CDZ is advising the biotechnology company Pharmena S.A. on the process of transferring shares to the Warsaw Stock Exchange from the NewConnect market where it has been listed since 2008.

On March 19, 2019, the Polish Financial Supervision Authority approved the company’s prospectus.

CDZ prepared the legal part of the prospectus, and in cooperation with the Brokerage House Vestor S.A. represented the client before the Polish Financial Supervision Authority in the proceeding regarding approval of the prospectus. Next, CDZ will advise on the process of listing and admission of Pharmena S.A. to the Warsaw Stock Exchange.

The team of CDZ lawyers is headed by Partner Maciej Kotlicki supported by Legal Advisor Piotr Rychta.